William Daniels is an accomplished healthcare strategist with over 17 years of experience in patient access, reimbursement, and program management. As the Principal Consultant at Daniels Consulting Group LLC, he provides expert leadership to pharmaceutical manufacturers, helping them develop and optimize patient access programs, including financial support, prescription conversion, patient engagement, adherence, and reimbursement initiatives. His work focuses on enhancing conversion and adherence rates while reducing time to therapy for patients, ensuring operational efficiency and high levels of customer satisfaction.

William has a proven track record of success, having led multiple initiatives that have delivered measurable results, including a significant $100K recovery due to billing discrepancies and the creation of a highly successful patient access program for clients. His expertise extends across co-pay support, pharmacy network management, and reimbursement strategy, and he is skilled in identifying and resolving complex data visibility issues to improve service provider outcomes.

Previously, William served as Director of Patient Support & Reimbursement at LEO Pharma, where he drove the strategic development of patient access programs, achieving a 52% conversion rate and exceeding patient adherence targets through innovative digital engagement solutions. At Conduent, he led the development of a next-generation CRM for patient assistance programs and secured $65M in new business through his contributions to RFP responses and business development efforts. His early career included key roles at Novartis and Regeneron Pharmaceuticals, where he demonstrated leadership in launching patient support programs and streamlining reimbursement processes, driving both operational savings and enhanced patient experiences.

Throughout his career, William has been recognized for his ability to build strong cross-functional teams, develop strategic relationships with key stakeholders, and implement innovative solutions that drive growth and improve patient access to care. With a deep understanding of pharmaceutical reimbursement processes and a commitment to patient advocacy, he continues to make a significant impact on the healthcare landscape.